Patients with severe hypertriglyceridemia (sHTG) achieved an 83% median reduction in triglycerides (TG), with 96% of patients achieving TG levels below 500 mg/dL, a threshold associated with increased ...
Demands Openness to Evaluating Credible Opportunities to Maximize Shareholder ValueUnderscores the Company’s Sustained Value Destruction, Lack of Permanent Leadership, and Board’s Poor Alignment with ...
WHEAT RIDGE, CO / ACCESS Newswire / March 27, 2026 / Lifeloc Technologies, Inc. (OTC:LCTC), a global leader in the ...
Acquisition integrates patent-pending algorithms and data insight engine into PetaSight’s operating system so pharmaceutical ...
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasisResults ...
Customer-first initiative helps specialty pharmacies and e-commerce leaders keep pace with the rapidly evolving GLP-1 ...
Homecare Feeding, Aging Population, and Technological Innovation Driving Global GrowthThe nasogastric intubation market is ...
Market OverviewThe global MedTech Contract Manufacturing Organization (CMO) market is witnessing robust growth, expanding at ...
March 26, 2026] A new report from Phacilitate argues that the biggest threat to cell and gene therapy (CGT) expansion is no ...
Reported positive preclinical results for lead drug candidate EB-003, showing statistically significant improvements in animal models of severe chronic depression and despair and in post-traumatic ...
For global buyers, the evolution of Chinese innovative drugs is no longer merely about “more choices” — it has become a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results